Methotrexate Side Effects

Methotrexate is a very old chemotherapy drug that was first approved by the US Food & Drug Administration back in 1953. It is used against several subtypes of cancer, both solid tumor cancers and lymphoma/leukemias. It is used alone and in combination chemotherapy regimens.

Since it is so old, methotrexate has a very well understood toxicity profile, allowing for the side effects to have been well documented.

Serious Side Effects of Methotrexate

The following side effects of methotrexate are considered serious enough that, should they be experienced, it is important to notify one's doctor or health care professional as soon as possible.

  • Any indication of an allergic reaction: Hives, problems breathing; the swelling of your face, lips, tongue, or throat
  • Vomiting or diarrhea, or the development of white patches or sores inside the mouth or on the lips
  • Blood in one's urine or stools
  • Urinating less frequently than usual, or not urinating at all
  • Signs of an infection, such as fever, chills, body aches and other flu-like symptoms
  • A sore throat and headache coupled with severe blistering, peeling and red skin rash
  • Easy bruising or bleeding, weakness, pale skin
  • Nausea, stomach pains, low fevers, appetite loss dark-colored urine, clay-colored stools, jaundice (yellowing of the skin or eyes)

Less Serious Side Effects of Methotrexate

The following presents an incomplete list of side effects associated with methotrexate considered to be less serious than those listed above. Simply because they are less serious does not mean they should not be reported to one's doctor. Instead, one should report all side effects to their doctor when they occur.

  • Bleeding gums
  • Dizziness or fatigue
  • Headaches
  • Nausea and/or vomiting
  • Blurred vision

Keep in mind that not all patients will experience side effects when receiving methotrexate. Some patients won't experience any, while others may experience many. Most probably fall somewhere in between the two extremes.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap